Targeting the RUNX2–TGF-β regulatory circuit to overcome cancer stem cell-mediated chemoresistance in triple-negative breast cancer: mechanisms, therapeutic opportunities, and translational challenges
Abstract Background. Chemoresistance in triple-negative breast cancer (TNBC) remains a critical driver of relapse and metastasis. Current explanatory models—EMT reversibility, the absence of upstream CSC drivers, TGF-β pleiotropy, and fragmented RUNX2 functions—exist in isolation, lacking a unified framework. Main body This review proposes the RUNX2-TGF-β positive feedback loop as a working hypothesis for a regulatory node that integrates these mechanisms. In this proposed circuit, TGF-β is postulated to activate RUNX2, which in turn amplifies TGF-β signaling, forming a self-reinforcing loop that is proposed to sustain CSC stemness, plasticity, metabolic adaptation, and drug tolerance. We synthesize the molecular evidence for this circuit, propose a candidate causal chain in chemoresistance, and critically evaluate cross-cancer evidence while distinguishing it from TNBC-specific findings. We then critically analyze why most targeted strategies succeed preclinically yet fail clinically, covering TGF-β inhibitor toxicity, RUNX2 “undruggability,” weak natural compound evidence, and the model-to-clinic gap. Conclusion Given the limited direct causal evidence in TNBC, the RUNX2-TGF-β circuit is presented here as a working hypothesis rather than an established resistance mechanism. We propose a translational validation roadmap and highlight key unresolved questions. Unlike previous reviews, this work explicitly grades the evidence for each link in the circuit and designs a falsifiable experiment to test whether circuit disruption reverses established chemoresistance.
Authors
- JiaRui Zhang
- Rilei Jiang (ORCID: https://orcid.org/0000-0002-5923-3912)
- Yiting Cao (ORCID: https://orcid.org/0000-0003-1452-908X)
- Ying Xu (ORCID: https://orcid.org/0000-0002-4516-5314)
- Qian Li
- Jun Hu
- Danni Cen
Institutions
- Tongji University (CN)
- Nanjing University of Chinese Medicine (CN)
- Cornell University (US)
- Shanghai University of Traditional Chinese Medicine (CN)
- Shuguang Hospital (CN)
- Shanghai First Maternity and Infant Hospital (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1186/s12967-026-09203-w
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 0.00